Almetax Manufacturing Faces Financial Challenges Amid Valuation Adjustment and Declining Sales
Almetax Manufacturing Co., Ltd. has recently experienced an evaluation adjustment, reflecting changes in its financial metrics. Key indicators include a high P/E ratio of 96, a low Price to Book Value of 0.34, and a modest Return on Equity of 0.36%, amidst declining net sales and a dividend yield of 0.19%.
Almetax Manufacturing Co., Ltd., a microcap player in the building products industry, has recently undergone an evaluation adjustment that reflects notable shifts in its financial metrics. The company's valuation score has been revised, indicating a change in its perceived worth in the market. Key financial indicators reveal a P/E ratio of 96, which suggests a significant premium compared to industry norms. The Price to Book Value stands at 0.34, while the EV to EBIT and EV to EBITDA metrics show negative values of -6.63 and -22.47, respectively. These figures highlight the complexities in the company's financial landscape.
Additionally, Almetax's Return on Equity (ROE) is reported at 0.36%, which points to challenges in generating profitability from shareholders' funds. The company has also experienced a decline in net sales, with an annual growth rate of -4.46% over the past five years.
Despite these challenges, Almetax maintains a dividend yield of 0.19%, which may attract certain investor segments. The recent evaluation adjustment reflects the ongoing dynamics within the company and the broader market context.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
